Adicet Bio, Inc. (ACET) Operating income 2017–2025
Adicet Bio, Inc. (ACET) annual operating income history from SEC filings — each fiscal year as reported.
-$122.1MFY2025 · since FY2017: -$18.9M → -$122.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$122.1M | +4.3% |
| FY2024 | -$127.6M | +16.1% |
| FY2023 | -$152.0M | -109.6% |
| FY2022 | -$72.6M | -18.1% |
| FY2021 | -$61.4M | -56.8% |
| FY2020 | -$39.2M | -24.9% |
| FY2019 | -$31.4M | -109.8% |
| FY2018 | -$15.0M | +20.7% |
| FY2017 | -$18.9M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More ACET financial trends
ACET RevenueACET Net incomeACET Net marginACET Gross profitACET Gross marginACET Operating marginACET Operating cash flowACET Free cash flowACET Capital expendituresACET Return on equityACET Stock buybacksACET Dividends paidACET Total assetsACET Total liabilitiesACET Shareholders’ equityACET overview →